{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:58:21Z","timestamp":1762541901528,"version":"build-2065373602"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.4158\/ep10118.ra","type":"journal-article","created":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T21:30:11Z","timestamp":1272922211000},"page":"874-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["New Horizons in Skeletal Physiology and Pathophysiology"],"prefix":"10.1016","volume":"16","author":[{"given":"Mone","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jameel","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP10118.RA_bb0010","doi-asserted-by":"crossref","first-page":"1677E-E","DOI":"10.1096\/fj.15.10.1677e","article-title":"Bone builders: The discoveries behind preventing and treating osteoporosis","volume":"15","author":"Patlak","year":"2001","journal-title":"FASEB J"},{"key":"10.4158\/EP10118.RA_bb0015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","article-title":"Skeletal remodeling in health and disease","volume":"13","author":"Zaidi","year":"2007","journal-title":"Nat Med"},{"key":"10.4158\/EP10118.RA_bb0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.4158\/EP10118.RA_bb0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bone.2010.04.594","article-title":"Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density","volume":"47","author":"Genant","year":"2010","journal-title":"Bone"},{"key":"10.4158\/EP10118.RA_bb0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat Med"},{"key":"10.4158\/EP10118.RA_bb0035","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature03398","article-title":"Leptin regulation of bone resorption by the sympathetic nervous system and CART","volume":"434","author":"Elefteriou","year":"2005","journal-title":"Nature"},{"key":"10.4158\/EP10118.RA_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0092-8674(03)00771-2","article-title":"TSH is a negative regulator of skeletal remodeling","volume":"115","author":"Abe","year":"2003","journal-title":"Cell"},{"key":"10.4158\/EP10118.RA_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","article-title":"FSH directly regulates bone mass","volume":"125","author":"Sun","year":"2006","journal-title":"Cell"},{"key":"10.4158\/EP10118.RA_bb0050","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.1073\/pnas.0912176107","article-title":"ACTH protects against glucocorticoid-induced osteonecrosis of bone","volume":"107","author":"Zaidi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP10118.RA_bb0055","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1073\/pnas.0901890106","article-title":"Oxytocin is an anabolic bone hormone","volume":"106","author":"Tamma","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP10118.RA_bb0060","series-title":"Bone Health and Osteoporosis: A Report of the Surgeon General.","first-page":"68","article-title":"The frequency of bone disease.","author":"Stepnick","year":"2004"},{"key":"10.4158\/EP10118.RA_bb0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2003-031183","article-title":"Change in estradiol and follicle-stimulating hormone across the early menopausal transition: Effects of ethnicity and age","volume":"89","author":"Randolph","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10118.RA_bb0070","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1210\/jc.2005-1836","article-title":"Hormone predictors of bone mineral density changes during the menopausal transition","volume":"91","author":"Sowers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10118.RA_bb0075","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1359\/JBMR.040710","article-title":"Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients","volume":"19","author":"Recker","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP10118.RA_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bone.2007.03.019","article-title":"Transmenopausal changes in the trabecular bone structure","volume":"41","author":"Akhter","year":"2007","journal-title":"Bone"},{"key":"10.4158\/EP10118.RA_bb0085","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7326\/0003-4819-130-9-199905040-00016","article-title":"The effect of thyroid hormone on skeletal integrity","volume":"130","author":"Greenspan","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP10118.RA_bb0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/thy.1994.4.319","article-title":"Hyperthyroidism, thyroid hormone therapy, and bone","volume":"4","author":"Ross","year":"1994","journal-title":"Thyroid"},{"key":"10.4158\/EP10118.RA_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/thy.1994.4.143","article-title":"Thyroid hormone and bone mass: The clinician's dilemma","volume":"4","author":"Baran","year":"1994","journal-title":"Thyroid"},{"key":"10.4158\/EP10118.RA_bb0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MED.0b013e3283328aee","article-title":"Role of the pituitary-bone axis in skeletal pathophysiology","volume":"16","author":"Imam","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.4158\/EP10118.RA_bb0105","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1001\/jama.1941.02820220007002","article-title":"Post menopausal osteoporosis","volume":"1167","author":"Albright","year":"1941","journal-title":"JAMA"},{"key":"10.4158\/EP10118.RA_bb0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"23","author":"Riggs","year":"2002","journal-title":"Endoc Rev"},{"key":"10.4158\/EP10118.RA_bb0115","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.130200197","article-title":"Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-jun repression","volume":"97","author":"Shevde","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP10118.RA_bb0120","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1074\/jbc.M010764200","article-title":"Estrogen decreases osteoclast formation by downregulating receptor activator for NF-kappa B ligand induced JNK activation","volume":"276","author":"Srivastava","year":"2001","journal-title":"J Biol Chem"},{"key":"10.4158\/EP10118.RA_bb0125","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1172\/JCI4561","article-title":"Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1","volume":"102","author":"Srivastava","year":"1998","journal-title":"J Clin Invest"},{"key":"10.4158\/EP10118.RA_bb0130","doi-asserted-by":"crossref","first-page":"13960","DOI":"10.1073\/pnas.251534698","article-title":"Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo","volume":"98","author":"Roggia","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP10118.RA_bb0135","doi-asserted-by":"crossref","first-page":"13720","DOI":"10.1074\/jbc.M410995200","article-title":"Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens","volume":"280","author":"Garc\u00eda Palacios","year":"2005","journal-title":"J Biol Chem"},{"key":"10.4158\/EP10118.RA_bb0140","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/endo.142.2.7977","article-title":"Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase","volume":"142","author":"Armour","year":"2001","journal-title":"Endocrinology"},{"key":"10.4158\/EP10118.RA_bb0145","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1172\/JCI119047","article-title":"Estrogen suppresses activation but enhances formation phase of osteogenic response to mechanical stimulation in rat bone","volume":"98","author":"Jagger","year":"1996","journal-title":"J Clin Invest"},{"key":"10.4158\/EP10118.RA_bb0150","doi-asserted-by":"crossref","first-page":"e586","DOI":"10.1371\/journal.pone.0000586","article-title":"Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency","volume":"2","author":"Wu","year":"2007","journal-title":"PLoS One"},{"key":"10.4158\/EP10118.RA_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbrc.2010.02.113","article-title":"Further evidence for direct pro-resorptive action of FSH","volume":"394","author":"Sun","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.4158\/EP10118.RA_bb0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbrc.2010.02.112","article-title":"FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoblasts","volume":"394","author":"Robinson","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.4158\/EP10118.RA_bb0165","doi-asserted-by":"crossref","first-page":"R790","DOI":"10.1152\/ajpregu.00728.2009","article-title":"Follicle-stimulating hormone, interleukin-1, and bone density in adult women","volume":"298","author":"Cannon","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.4158\/EP10118.RA_bb0170","doi-asserted-by":"crossref","first-page":"14925","DOI":"10.1073\/pnas.0606805103","article-title":"Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation","volume":"103","author":"Iqbal","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP10118.RA_bb0175","first-page":"S64","article-title":"CD40L mediated T cell activation is required for estrogen deficiency to induce bone loss. Proceedings of the 31st Annual Meeting of the American Society for Bone and Mineral Research Denver, Colorado","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP10118.RA_bb0180","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1196\/annals.1402.056","article-title":"Proresorptive actions of FSH and bone loss","volume":"1116","author":"Zaidi","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.4158\/EP10118.RA_bb0185","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1210\/en.2006-1404","article-title":"Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone","volume":"148","author":"Gao","year":"2007","journal-title":"Endocrinology"},{"key":"10.4158\/EP10118.RA_bb0190","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1006\/bbrc.2001.4246","article-title":"Sex- and age-related response to aromatase deficiency in bone","volume":"280","author":"Miyaura","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.4158\/EP10118.RA_bb0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S8756-3282(01)00643-3","article-title":"Deletion of estrogen receptors reveals a regulatory role for estrogen receptor-beta in bone remodeling in females but not in males","volume":"30","author":"Sims","year":"2002","journal-title":"Bone"},{"key":"10.4158\/EP10118.RA_bb0200","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"10.4158\/EP10118.RA_bb0205","series-title":"J Clin Endocrinol Metab.","article-title":"Effects of suppression of follicle stimulating hormone secretion on bone resorption markers in postmenopausal women","author":"Drake","year":"2010"},{"key":"10.4158\/EP10118.RA_bb0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00198-002-1329-4","article-title":"Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN","volume":"14","author":"Sowers","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP10118.RA_bb0215","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2008.09.027","article-title":"Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women","volume":"400","author":"Xu","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.4158\/EP10118.RA_bb0220","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1210\/jc.2009-0659","article-title":"Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause","volume":"95","author":"Sower","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10118.RA_bb0225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11914-009-0021-4","article-title":"Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss","volume":"7","author":"Zaidi","year":"2009","journal-title":"Curr Osteoporos Rep"},{"key":"10.4158\/EP10118.RA_bb0230","first-page":"360","article-title":"Hypergonadotropic amenorrhea and bone density: New approach to an old problem","volume":"22","author":"Devleta","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP10118.RA_bb0235","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/0022034509358822","article-title":"FSH aggravates periodontitis-related bone loss in ovariectomized rats","volume":"89","author":"Liu","year":"2010","journal-title":"J Dent Res"},{"key":"10.4158\/EP10118.RA_bb0240","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.joen.2010.01.011","article-title":"Protective effects of follicle-stimulating hormone inhibitor on alveolar bone loss resulting from experimental periapical lesions in ovareictomized rats","volume":"36","author":"Liu","year":"2010","journal-title":"J Endod"},{"key":"10.4158\/EP10118.RA_bb0245","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/EJE-10-0043","article-title":"FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women","volume":"163","author":"Rendina","year":"2010","journal-title":"Eur J Endocrinol"},{"year":"1891","series-title":"Die Fibrose Oder Deformierende Ostitis, die Osteomalazie und die Osteoplastische Carzinose in Ihren Gegenseitigen Beziehungen","author":"Von Recklinghausen","key":"10.4158\/EP10118.RA_bb0250"},{"key":"10.4158\/EP10118.RA_bb0255","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2265.2004.02053.x","article-title":"The thyroid and the skeleton","volume":"61","author":"Murphy","year":"2004","journal-title":"Clin Endocrol (Oxf)"},{"key":"10.4158\/EP10118.RA_bb0260","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1089\/thy.1994.4.508","article-title":"Thyroid hormone and bone","volume":"4","author":"Wenzel","year":"1994","journal-title":"Thyroid"},{"key":"10.4158\/EP10118.RA_bb0265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1677\/joe.0.1330327","article-title":"Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect","volume":"133","author":"Allain","year":"1992","journal-title":"J Endocrinol"},{"key":"10.4158\/EP10118.RA_bb0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1210\/endo.134.1.8275930","article-title":"Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption","volume":"134","author":"Britto","year":"1994","journal-title":"Endocrinology"},{"key":"10.4158\/EP10118.RA_bb0275","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1210\/me.2007-0033","article-title":"Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism","volume":"21","author":"Bassett","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.4158\/EP10118.RA_bb0280","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000182315","article-title":"Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma","volume":"37","author":"De Menis","year":"1992","journal-title":"Horm Res"},{"key":"10.4158\/EP10118.RA_bb0285","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1507\/endocrj.50.657","article-title":"Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism","volume":"50","author":"Kisakol","year":"2003","journal-title":"Endocr J"},{"key":"10.4158\/EP10118.RA_bb0290","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2265.1993.tb02403.x","article-title":"Bone mineral density in patients with endogenous subclinical hyperthyroidism: Is this thyroid status a risk factor for osteoporosis?","volume":"39","author":"F\u00f6ldes","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP10118.RA_bb0295","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/thy.1999.9.539","article-title":"Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women","volume":"9","author":"G\u00fcrlek","year":"1999","journal-title":"Thyroid"},{"key":"10.4158\/EP10118.RA_bb0300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-134-7-200104030-00009","article-title":"Risk for fracture in women with low serum levels of thyroid-stimulating hormone","volume":"134","author":"Bauer","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP10118.RA_bb0305","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bone.2006.12.001","article-title":"The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women","volume":"40","author":"Morris","year":"2007","journal-title":"Bone"},{"key":"10.4158\/EP10118.RA_bb0310","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1089\/thy.2006.16.1075","article-title":"Low TSH triggers bone loss: Fact or fiction?","volume":"16","author":"Zaidi","year":"2006","journal-title":"Thyroid"},{"key":"10.4158\/EP10118.RA_bb0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0092-8674(03)00812-2","article-title":"TSH, the bone suppressing hormone","volume":"115","author":"Novack","year":"2003","journal-title":"Cell"},{"key":"10.4158\/EP10118.RA_bb0320","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1073\/pnas.0600427103","article-title":"TNFalpha mediates the skeletal effects of thyroid-stimulating hormone","volume":"103","author":"Hase","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP10118.RA_bb0325","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1073\/pnas.0712395105","article-title":"Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss","volume":"105","author":"Sun","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP10118.RA_bb0330","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/joe.0.1600097","article-title":"Thyroid hormone stimulates basal and interleukin (IL)-1-induced IL-6 production in human bone marrow stromal cells: A possible mediator of thyroid hormone-induced bone loss","volume":"160","author":"Kim","year":"1999","journal-title":"J Endocrinol"},{"key":"10.4158\/EP10118.RA_bb0335","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1359\/JBMR.041126","article-title":"Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma","volume":"20","author":"Mazziotti","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP10118.RA_bb0340","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1359\/jbmr.070302","article-title":"Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats","volume":"22","author":"Sampath","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP10118.RA_bb0345","doi-asserted-by":"crossref","first-page":"304","DOI":"10.14310\/horm.2002.1111026","article-title":"Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma","volume":"6","author":"Giusti","year":"2007","journal-title":"Hormones (Athens)"},{"key":"10.4158\/EP10118.RA_bb0350","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/thy.2007.0166","article-title":"The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels","volume":"18","author":"Martini","year":"2008","journal-title":"Thyroid"},{"key":"10.4158\/EP10118.RA_bb0355","first-page":"121","article-title":"Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women","volume":"42","author":"Zofkova","year":"2008","journal-title":"Endocr Regul"},{"key":"10.4158\/EP10118.RA_bb0360","first-page":"475","article-title":"L-thyroxin treatment and post-menopausal osteoporosis: Relevance of the risk profile present in clinical history","volume":"60","author":"La Vignera","year":"2008","journal-title":"Minerva Ginecol"},{"key":"10.4158\/EP10118.RA_bb0365","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-08-0038","article-title":"Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma","volume":"159","author":"Heemstra","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP10118.RA_bb0370","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2007.0186","article-title":"High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy","volume":"18","author":"Mikosch","year":"2008","journal-title":"Thyroid"},{"key":"10.4158\/EP10118.RA_bb0375","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/thy.2008.0158","article-title":"The relationship between serum TSH and bone mineral density in men and postmenopausal women: The Troms\u00f8 study","volume":"18","author":"Grimnes","year":"2008","journal-title":"Thyroid"},{"key":"10.4158\/EP10118.RA_bb0380","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-09-0139","article-title":"Hyperthyroid levels of TSH correlate with low bone mineral density: The HUNT 2 Study","volume":"161","author":"Svare","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP10118.RA_bb0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4149\/endo_2010_01_9","article-title":"The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women","volume":"44","author":"Baqi","year":"2010","journal-title":"Endocr Regul"},{"key":"10.4158\/EP10118.RA_bb0390","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1507\/endocrj.K06-201","article-title":"Subclinical hypothyroidism is related to lower heel QUS in postmenopausal women","volume":"54","author":"Nagata","year":"2007","journal-title":"Endocr J"},{"key":"10.4158\/EP10118.RA_bb0395","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bone.2009.10.031","article-title":"Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density","volume":"46","author":"Mazziotti","year":"2010","journal-title":"Bone"},{"key":"10.4158\/EP10118.RA_bb0400","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2265.2007.03016.x","article-title":"Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: The Rotterdam Study","volume":"68","author":"van der Deure","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP10118.RA_bb0405","first-page":"S341","article-title":"The D272E polymorphism of the human thyroid stimulating hormone receptor is associated with bone mineral density and bone loss in women from the UK","volume":"20","author":"Albagha","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP10118.RA_bb0410","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.maturitas.2008.09.010","article-title":"A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density","volume":"61","author":"Rannevik","year":"2008","journal-title":"Maturitas"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20415319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20415319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/68813616197P323T.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:51:32Z","timestamp":1761515492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20415319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1530891X20415319"],"URL":"https:\/\/doi.org\/10.4158\/ep10118.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Horizons in Skeletal Physiology and Pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP10118.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}